Acquired
Novo Nordisk (Ozempic)
Ben Gilbert
Everyone's insulin has gotten more expensive and they come under fire in the public eye. And so this sort of Saxenda not being the blockbuster drug that expectations had trumpeted it up to be, plus this increasing pressure around Insulin and I think a CEO change.
0
💬
0
Comments
Log in to comment.
There are no comments yet.